Skip to main content

Home
Browse by Topic
Issues
PSS Guide
- Index
- Introduction
Special Series
Multimedia
Subscribe

Home
Browse by Topic
Issues
PSS Guide
- Index
- Introduction
Special Series
Multimedia
Subscribe

Wallace Akerley, MD

Professor of Medicine
Thoracic Oncology
Huntsman Cancer Institute at University of Utah
Salt Lake City, UT

Authored Items

Best Practices: Biomarkers and Treatment Selection in the Management of Advanced NSCLC

By Wallace Akerley, MD; Katie Kerrigan, DO

Best Practices: Biomarkers and Treatment Selection in the Management of Advanced NSCLC

Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of patients with advanced non–small-cell lung cancer (NSCLC) by demonstrating significantly better outcomes and tolerability than conventional chemotherapy. Read More ›

Home
About
Contact Us
Subscribe

© Amplity Health. All Rights Reserved. Privacy Policy.

Subscribe Today!

To sign up for our free e-Newsletter or print publications, please enter your contact information below.

I'd like to receive:

OPM e-Newsletter

OPM print publication

I have reviewed and consent to the terms of OPM's Privacy Policy, and OPM has my permission to retain my information in its database, and to forward pertinent communications to me.